Heron Neutron Medical Corp. (TPE:7799)

Market Cap	61.43B +8.4%
Revenue (ttm)	12.96M +5,561.1%
Net Income	-457.60M
EPS	-2.91
Shares Out	157.51M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	713,970
Open	325.50
Previous Close	323.50
Day's Range	325.50 - 355.50
52-Week Range	300.00 - 984.00
Beta	n/a
Analysts	Strong Buy
Price Target	1,203.33 (+238.49%)
Earnings Date	Jul 24, 2026

About Heron Neutron Medical

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Employees: 104
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 7799

Analyst Summary

According to 3 analysts, the average rating for 7799 stock is "Strong Buy." The 12-month stock price target is $1,203, which is an increase of 238.49% from the latest price.

Price Target

$1,203

(238.49% upside)

Analyst Consensus: Strong Buy